Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function

被引:391
作者
Curtsinger, JM [1 ]
Lins, DC [1 ]
Mescher, MF [1 ]
机构
[1] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
关键词
antigens; cell division; immune tolerance; interleukin-12; lymphocytes;
D O I
10.1084/jem.20021910
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of naive CD8 T cells to undergo clonal expansion and develop effector function requires three signals: (a) Ag, (b) costimulation, and (c) IL-12 or adjuvant. The requirement for the third signal to stimulate Ag-dependent proliferation is variable, making the greatest contribution when Ag levels are low. At high Ag levels, extensive proliferation can occur in vitro or in vivo in the absence of a third signal. However, despite having undergone the same number of divisions, cells that expand in the absence of a third signal fail to develop cytolytic effector function. Thus, proliferation and development of cytolytic function can be fully uncoupled. Furthermore, these cells are rendered functionally tolerant in vivo, in that subsequent restimulation with a potent stimulus results in limited clonal expansion, impaired IFN-gamma production, and no cytolytic function. Thus, the presence or absence of the third signal appears to be a critical variable in determining whether stimulation by Ag results in tolerance versus development of effector function and establishment of a responsive memory population.
引用
收藏
页码:1141 / 1151
页数:11
相关论文
共 58 条
  • [1] Toll-like receptors in the induction of the innate immune response
    Aderem, A
    Ulevitch, RJ
    [J]. NATURE, 2000, 406 (6797) : 782 - 787
  • [2] T-CELL PRIMING VERSUS T-CELL TOLERANCE INDUCED BY SYNTHETIC PEPTIDES
    AICHELE, P
    BRDUSCHARIEM, K
    ZINKERNAGEL, RM
    HENGARTNER, H
    PIRCHER, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 261 - 266
  • [3] Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
    Albert, ML
    Jegathesan, M
    Darnell, RB
    [J]. NATURE IMMUNOLOGY, 2001, 2 (11) : 1010 - 1017
  • [4] DIABETES IN TRANSGENIC MICE RESULTING FROM OVER-EXPRESSION OF CLASS-I HISTOCOMPATIBILITY MOLECULES IN PANCREATIC BETA-CELLS
    ALLISON, J
    CAMPBELL, IL
    MORAHAN, G
    MANDEL, TE
    HARRISON, LC
    MILLER, JFAP
    [J]. NATURE, 1988, 333 (6173) : 529 - 533
  • [5] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [6] HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
    Appay, V
    Nixon, DF
    Donahoe, SM
    Gillespie, GMA
    Dong, T
    King, A
    Ogg, GS
    Spiegel, HML
    Conlon, C
    Spina, CA
    Havlir, DV
    Richman, DD
    Waters, A
    Easterbrook, P
    McMichael, AJ
    Rowland-Jones, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) : 63 - 75
  • [7] The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens
    Belz, GT
    Behrens, GMN
    Smith, CM
    Miller, JFAP
    Jones, C
    Lejon, K
    Fathman, CG
    Mueller, SN
    Shortman, K
    Carbone, FR
    Heath, WR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (08) : 1099 - 1104
  • [8] CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) : 1283 - 1288
  • [9] T-CELL TOLERANCE BY CLONAL ANERGY IN TRANSGENIC MICE WITH NONLYMPHOID EXPRESSION OF MHC CLASS-II I-E
    BURKLY, LC
    LO, D
    KANAGAWA, O
    BRINSTER, RL
    FLAVELL, RA
    [J]. NATURE, 1989, 342 (6249) : 564 - 566
  • [10] Coordinate regulation of complex T cell populations responding to bacterial infection
    Busch, DH
    Pilip, IM
    Vijh, S
    Pamer, EG
    [J]. IMMUNITY, 1998, 8 (03) : 353 - 362